ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,099.60
0.16%
Dow Jones
40,003.59
0.34%
Brent Oil
83.775
0.22%
Bitcoin
66,806.20
0.98%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Accolade Inc (ACCD)

  7. Accolade Inc (ACCD) News

Accolade Inc

Accolade Inc (ACCD)

NASDAQ
7.48
0.15
(2.05%)
Closed May 17 4:00PM
Delayed by 15 minutes
7.48
0.00
( 0.00% )
Pre Market: 4:05AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

ACCD News

Official News Only

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
May 17 2024
ACCD (2.05%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
May 14 2024
ACCD (2.05%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
May 13 2024
ACCD (2.05%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 05 2024
ACCD (2.05%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 05 2024
ACCD (2.05%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 05 2024
ACCD (2.05%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 05 2024
ACCD (2.05%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
March 04 2024
ACCD (2.05%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
March 04 2024
ACCD (2.05%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 04 2024
ACCD (2.05%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 04 2024
ACCD (2.05%)

ACCD Discussion

View Posts
Monksdream Monksdream 9 months ago
That awful Cathie Wood bought more shares

👍️0
Monksdream Monksdream 10 months ago
ACCD That awful Cathie Wood bought shares.
Accolade Inc NASDAQ: ACCD

GoSymbol lookup
Health Care : Health Care Providers & Services | Small Cap BlendCompany profile
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
👍️0
forthepeach forthepeach 2 years ago
Will this help their stock price?
https://finance.yahoo.com/news/accolade-expands-mental-health-integrated-130000009.html
👍️0
swampboots swampboots 2 years ago
ACCD down 50% will lose big customer end of year and always has loses on increased revenue, spends a ton on research and dev.
👍️0
crudeoil24 crudeoil24 2 years ago
Accolade Sees Q4 Sales $90M-$93M vs $97.71M Est., Raises FY22 Sales Guidance From $303M-$307M To $306M-$309M vs $306.34M Est.
👍️0
crudeoil24 crudeoil24 2 years ago
Accolade Inc. is a provider of personalized, technology-enabled solutions that helps people to understand, navigate, and utilize the healthcare system and their workplace benefits. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The Company leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.
👍️0

Your Recent History

NASDAQ
ACCD
Accolade
BOV
CYRE3
CYRELA REALT ON
BIT
MB
Mediobanca Banca di Cred...
NASDAQ
UOPX
Apollo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
NASDAQ
ASCAU
A SPAC I Acquisition
AQSE
LFT
Lift Global Ventures
NASDAQ
ASTL
Algoma Steel
AMEX
AETH
Bitwise Ethereum Strateg...
NASDAQ
AGIIL
NASDAQ
ALGS
Aligos Therapeutics
NASDAQ
OCAX
OCA Acquisition
NASDAQ
AKUS
Akouos
NASDAQ
OLGR
Oilgear
NASDAQ
AIMD
Ainos
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved